 |
Epstein-Barr virus-specific autologous cytotoxic T lymphocytes |
|---|---|
| Trade Name | |
| Orphan Indication | Epstein-Barr virus positive head and neck cancers (which includes nasopharyngeal carcinoma) |
| USA Market Approval | USA |
| USA Designation Date | 2014-06-12 00:00:00 |
| Sponsor | Tessa Therapeutics Pte.;8 Temasek Blvd #24-02, Suntec Tower Three; |
